2017_SBRT_Course Book

Department of Radiation Oncology University Hospital Zurich Chairman: Prof. Dr. Matthias Guckenberger

SBRT for Prostate Cancer

Matthias Guckenberger

Question Which answer is correct in prostate SBRT? 1. SBRT for prostate cancer is especially well evaluated in high-risk disease. 2. Especially GI and not GU toxicity is an issue of concern in SBRT for prostate cancer. 3. SBRT is using most frequently 5 fraction of doses between 35 – 40Gy.

/ 07.09.17 Matthias Guckenberger - ESTRO SBRT Course 2017

/ 2